Difference between revisions of "Team:CGU Taiwan/Parts"

 
(47 intermediate revisions by 5 users not shown)
Line 1: Line 1:
 
<html>
 
<html>
 
<meta http-equiv="X-UA-Compatible" content="IE=edge">
 
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
 
 
<style>
 
<style>
 
 
         #sideMenu
 
         #sideMenu
 
         {
 
         {
Line 16: Line 14:
 
#content { padding:0px; width:100%; margin-left:0%; margin-right:0%;}
 
#content { padding:0px; width:100%; margin-left:0%; margin-right:0%;}
 
</style>
 
</style>
 
<head>
 
<meta charset="utf-8">
 
<meta http-equiv="X-UA-Compatible" content="IE=edge">
 
<meta name="viewport" content="width=device-width, initial-scale=1">
 
</head>
 
 
<!-- ////////////////////// START  TOP HEADER /////////////////////// -->
 
<!-- ////////////////////// START  TOP HEADER /////////////////////// -->
 
<head>
 
<head>
Line 30: Line 22:
 
.top {
 
.top {
 
   position: absolute;
 
   position: absolute;
   top: -10px;
+
   top: -1%;
   left: 0px;
+
   left: 0%;
  background:  #140731;
+
 
   width: 100%;
 
   width: 100%;
   height: 110px;
+
  box-sizing:border-box;
 +
   height: 115px;
 
   font-family: Corbel;
 
   font-family: Corbel;
   overflow: visible;
+
   overflow:visible;
 +
  z-index: +1;
 
}
 
}
 
.mid {
 
.mid {
 
   position: absolute;
 
   position: absolute;
   left: 0px;
+
   left: 5%;
   width: 40%;
+
   width: 80%;
   height: 120%;
+
   height: 100%;
 
   font-family: Corbel;
 
   font-family: Corbel;
  z-index:-1;
 
 
}  
 
}  
 
.headline {
 
.headline {
  font-size:45px;
 
 
   color: #ffe;
 
   color: #ffe;
 
   text-align: center;
 
   text-align: center;
   padding-top: 30px;
+
   padding-top: 40px;
   padding-bottom: 40px;
+
   padding-bottom: 60px;
 
}
 
}
 
.header-subnav  {
 
.header-subnav  {
   background: #140731;
+
   background: #0D014D;
 
   width: 100%;
 
   width: 100%;
 
   position: absolute;
 
   position: absolute;
 
   text-align: center;
 
   text-align: center;
 
   margin: 0 auto;
 
   margin: 0 auto;
   top: 100px;
+
   top: 116%;
  left:-20px;
+
  left: 0%;
 
   font-family: Corbel;
 
   font-family: Corbel;
 +
  z-index:-1;
 
}
 
}
 
.header-subnav li {
 
.header-subnav li {
Line 93: Line 85:
 
.circle {
 
.circle {
 
   position:absolute;
 
   position:absolute;
   left: 1110px;
+
   left: 85.5%;
   top: 30px;
+
   top: 70%;
 
   width: 180px;
 
   width: 180px;
 
   height: 180px;
 
   height: 180px;
   background: #140731;
+
   background: #0D014D;
 
   -moz-border-radius: 90px;
 
   -moz-border-radius: 90px;
 
   -webkit-border-radius: 90px;
 
   -webkit-border-radius: 90px;
Line 105: Line 97:
 
   position: fixed;
 
   position: fixed;
 
   left: 25px;
 
   left: 25px;
   top: 200px;
+
   top: 230px;
 
   font-family: Corbel;
 
   font-family: Corbel;
 
   background: rgba(250, 250, 250, 0.15);
 
   background: rgba(250, 250, 250, 0.15);
Line 161: Line 153:
 
   width: 600px;
 
   width: 600px;
 
   height: 500px;
 
   height: 500px;
  border-top: solid 45px white;
 
  border-right: solid 5px white;
 
  border-bottom: solid 5px white;
 
  border-left: solid 5px white;
 
 
   position: absolute;
 
   position: absolute;
 
   z-index: 1;
 
   z-index: 1;
Line 238: Line 226:
 
.tab4:checked ~ ul{
 
.tab4:checked ~ ul{
 
   transform: translateY(-1500px);
 
   transform: translateY(-1500px);
 +
}
 +
 +
hr1 {
 +
  border: 0;
 +
  width: 80%;
 +
  color: #140731;
 +
  background-color: #140731;
 +
  height: 2px;
 +
}
 +
 +
hr {
 +
  border: 0;
 +
  width: 80%;
 +
  color: #FF8800;
 +
  background-color: #FF8800;
 +
  height: 2px;
 +
}
 +
.list li {
 +
  list-style:none;
 +
  background-image:url(https://static.igem.org/mediawiki/2016/b/ba/CGU_Taiwan--point.jpg);
 +
  background-repeat:no-repeat;
 +
  background-position:-10 5px;
 +
  padding-left:3%;
 +
  background-size:2.5%;
 +
}
 +
 +
.end2 {
 +
  background-color:#0D014D;
 +
  position: absolute;
 +
  width: 100%;
 +
  height: 285%;
 +
  font-family: Corbel;
 +
  z-index:+1;
 +
}
 +
.sitemap {
 +
  background-color:#0D014D;
 +
  position: absolute;
 +
  width: 20%;
 +
  height: 40%;
 +
  font-family: Corbel;
 +
}
 +
.list1 li {
 +
  list-style:none;
 +
  background-image:url(https://static.igem.org/mediawiki/2016/5/58/CGU_Taiwan--sitemap.jpg);
 +
  background-repeat:no-repeat;
 +
  background-position:10px;
 +
  background-size:9%;
 +
    margin-bottom:-20%;
 +
}
 +
.list2 li {
 +
  list-style:none;
 +
  background-image:url(https://static.igem.org/mediawiki/2016/2/2f/CGU_Taiwan--sitemap2.jpg);
 +
  background-repeat:no-repeat;
 +
  background-position:6px;
 +
  background-size:7%;
 +
  margin-bottom:-10%;
 +
}
 +
.list3 li {
 +
  list-style:none;
 +
  background-image:url(https://static.igem.org/mediawiki/2016/3/31/CGU_Taiwan--sitemap3.jpg);
 +
  background-repeat:no-repeat;
 +
  background-position:5%;
 +
  background-size:2%;
 +
  margin-bottom:-10%;
 
}
 
}
 
</style>
 
</style>
Line 257: Line 309:
  
 
//USE SCROLL WHEEL FOR THIS FIDDLE DEMO
 
//USE SCROLL WHEEL FOR THIS FIDDLE DEMO
 +
 +
 +
</script>
 +
<script>
 +
var slideIndex = 1;
 +
showDivs(slideIndex);
 +
 +
function plusDivs(n) {
 +
  showDivs(slideIndex += n);
 +
}
 +
 +
function currentDiv(n) {
 +
  showDivs(slideIndex = n);
 +
}
 +
 +
function showDivs(n) {
 +
  var i;
 +
  var x = document.getElementsByClassName("mySlides");
 +
  var dots = document.getElementsByClassName("demo");
 +
  if (n > x.length) {slideIndex = 1}
 +
  if (n < 1) {slideIndex = x.length}
 +
  for (i = 0; i < x.length; i++) {
 +
    x[i].style.display = "none";
 +
  }
 +
  for (i = 0; i < dots.length; i++) {
 +
    dots[i].className = dots[i].className.replace(" w3-border-red", "");
 +
  }
 +
  x[slideIndex-1].style.display = "block";
 +
  dots[slideIndex-1].className += " w3-border-red";
 +
}
 
</script>
 
</script>
  
 
<body>
 
<body>
<div class="top">
 
<img alt="" style="position:absolute;z-index:++1;float:left;margin-top:20px;width:390px;height:80px;"  src="https://static.igem.org/mediawiki/2016/b/bb/CGU_Taiwan--logo2.jpg">
 
<img style="position:absolute;left:1120px;top:35px;z-index:+1;width:155px;height:180px;" src="https://static.igem.org/mediawiki/2016/8/8a/CGU_Taiwan--logo9.jpg">
 
 
<a name='anchor0'></a>
 
<a name='anchor0'></a>
<div class="circle"></div>
+
<div class="top">
 +
<img style="margin-top:-2%;width:100%;height:140%;position:absolute;" src="https://static.igem.org/mediawiki/2016/0/0b/CGU_Taiwan--top.jpg">
 +
</div>
 
</div>
 
</div>
  
 
<header class="top">
 
<header class="top">
<h1 class="headline">Leijuvant <small></small></h1>
 
 
<ul class="header-subnav">
 
<ul class="header-subnav">
 
<li><a href="https://2016.igem.org/Team:CGU_Taiwan">HOME</a></li>
 
<li><a href="https://2016.igem.org/Team:CGU_Taiwan">HOME</a></li>
 
<li><a href="https://2016.igem.org/Team:CGU_Taiwan/Achievements">ACHIEVEMENTS</a></li>
 
<li><a href="https://2016.igem.org/Team:CGU_Taiwan/Achievements">ACHIEVEMENTS</a></li>
<li><a href="https://2016.igem.org/Team:CGU_Taiwan/Project">PROJECT</a></li>
+
<li><a href="https://2016.igem.org/Team:CGU_Taiwan/Description">PROJECT</a></li>
<li><a href="https://2016.igem.org/Team:CGU_Taiwan/Model">MODELING</a></li>
+
<li><a href="https://2016.igem.org/Team:CGU_Taiwan/Software">MODELING</a></li>
 
<li><a href="https://2016.igem.org/Team:CGU_Taiwan/Human_Practices">HUMAN PRACTICES</a></li>
 
<li><a href="https://2016.igem.org/Team:CGU_Taiwan/Human_Practices">HUMAN PRACTICES</a></li>
 
<li><a href="https://2016.igem.org/Team:CGU_Taiwan/Team">PEOPLE</a></li>
 
<li><a href="https://2016.igem.org/Team:CGU_Taiwan/Team">PEOPLE</a></li>
Line 280: Line 360:
 
<li><a href="https://2016.igem.org/Team:CGU_Taiwan/Parts">PARTS</a></li>
 
<li><a href="https://2016.igem.org/Team:CGU_Taiwan/Parts">PARTS</a></li>
 
</ul>
 
</ul>
 +
<div class="circle"><img style="position:absolute;z-index:+1;width:90%;height:95%;margin-left:3%;margin-top:2%;" src="https://static.igem.org/mediawiki/2016/8/8a/CGU_Taiwan--logo9.jpg"></div>
 
</header>
 
</header>
  
  
  
<div class="mid" style="margin-left:50px;top:200px;background-color:white;">
+
<div class="mid" style="margin-left:5%;margin-top:20%;">
In our 2016 iGEM project, immune and protein information searching is inevitably required. Therefore, McHug is a software platform that is created to arrange your data and search the protein infomation from several databases. We will output your data with a user-friendly interface and you can easily browse the results by submitting in a requested form. The concept of McHug software is originated from 2016 CGU iGEM group. We aim to test the potential of Leishmania to be a new vaccine adjuvant by carrying antigens directly into immune cells. The antigen peptides will be presented on MHCI or II molecules to activate T cells. Therefore, McHug is created to predict the peptides on MHC molecules and help to optimize the peptide presentation and T cell activation. Also, cloning efficiency is considered to be an important step of the experiment. We then expect that this platform and help us shorten the antigen sequence so that it can be more effective to subclone the shuttle vector. The major functions of McHug can be sorted into 3 parts:<br>
+
<br>
<span style="font-weight:bold;">1. Protein Structure</span><br>
+
<div style="font-size:60px;color:#9F4D95 ;text-decoration:none;">
Protein structure can affect the possibility of being epitope. Peptides in strong structural sequences like alpha-helix have small chance to be antigenic determinant. On the other hand, sequences in loop structure tend to be recognized by the immune system, specifically by antibodies, B cells, or T cells. Here, McHug shows you the 3D structure of your protein and you can select the peptide sequence to be colored. In case you want to design an epitope sequence to generate antibodies, you can choose sequences on the protein surface in a visible way.<br>
+
Biobricks
<span style="font-weight:bold;">2. MHC Affinity Graphs</span><br>
+
Pathogenic proteins will be chopped into peptides and presented by MHC molecules to activate T cells. Therefore, the prediction of MHC affinity in your protein sequence can help you design your experiment. McHug is generated to arrange your numerical data into an easy understanding graph. We can show your IEDB prediction result in a trend chart. Also, users can enter the affinity threshold to curtail the signal in low-affinity position. Each affinity of amino acid in the chart stands for the nonamer starting from the specific amino acid position. Users can easily choose the high-affinity sequence and optimize their experiment.<br>
+
<span style="font-weight:bold;">3. Modification Sites</span><br>
+
McHug will provide you the basic information of protein modifications. Moreover, the modification sites will be shown correspondingly to the amino acid position of MHC affinity chart. With the information, users can twig the profile of the protein.<br>
+
<span style="font-weight:bold;">4. Conservation Level</span><br>
+
Protein conservation level will be given after BLASTing and multiple sequence aligning the submitted protein sequence. The outcome indicates the protein sequence conservation level between homologous protein sequences in different species. The conservation data will also be shown correspondingly to the amino acid position of MHC affinity chart. Users can choose the highly conserved peptide sequence to perform their experiment. In the project of CGU iGEM 2016, highly conserved region of pathogenic antigens sequence indicates a higher common share of pathogens. This can ensure the high coverage of the vaccine. (Future Work)<br>
+
 
</div>
 
</div>
 +
<br><br>
  
 +
<div style="width:500px;color:black;text-decoration:none;font-size:18px;margin-left:70px;border:2px black solid;border-radius:8px;padding:15px;">
 +
<b>1. Basic part:</b>
 +
<br>
 +
<a href="http://parts.igem.org/Part:BBa_K1955000">BBa_K1955000 </a>: pSB1C3-Hemagglutinin
 +
<br>
 +
<a href="http://parts.igem.org/Part:BBa_K1955001">BBa_K1955001</a>: pSB1C3-2.3intron
 +
<br>
 +
<a href="http://parts.igem.org/Part:BBa_K1955002">BBa_K1955002</a>: pSB1C3-3'UTR
 +
<br>
 +
<a href="http://parts.igem.org/Part:BBa_K1955003">BBa_K1955003</a>: pSB1C3-5'HYG
 +
<br>
 +
<a href="http://parts.igem.org/Part:BBa_K1955004">BBa_K1955004</a>: pSB1C3-Ova
 +
<br><br>
 +
<b>2. Composite parts:</b>
 +
<br>
 +
<a href="http://parts.igem.org/Part:BBa_K1955005">BBa_K1955005 </a>: pSB1C3-5'HYG-HA-3'UTR
 +
<br>
 +
<a href="http://parts.igem.org/Part:BBa_K1955006">BBa_K1955006 </a>: pSB1C3-5'HYG-OVA-3'UTR
 +
<br>
 +
<a href="http://parts.igem.org/Part:BBa_K1955007">BBa_K1955007 </a>: pSB1C3-5'HYG-GFP-3'UTR
 +
<br>
 +
<a href="http://parts.igem.org/Part:BBa_K1955008">BBa_K1955008 </a>: pSB1C3-lacI inducible Hemagglutinin
 +
<br>
 +
<a href="http://parts.igem.org/Part:BBa_K1955008">BBa_K1955010 </a>: pSB1A2-lacI inducible GFP
 +
<br>
  
 +
</div>
  
<div class="mid" style="margin-left:630px;top:200px;background-color:white;">
+
<br><br><br>
Demo
+
<b style="font-size:20px;">(1) Insert 5’HYG (<a href="http://parts.igem.org/Part:BBa_K1955003">BBa_K1955003</a>), 3’UTR (<a href="http://parts.igem.org/Part:BBa_K1955002">BBa_K1955002</a>), HA (<a href="http://parts.igem.org/Part:BBa_K1955000">BBa_K1955000</a>) and OVA (<a href="http://parts.igem.org/Part:BBa_K1955004">BBa_K1955004</a>) gBlocks into pSB1C3 vector:</b>
This demo clip was filmed to showcase how to use McHug software and explan the function of result page. The protein ID we used in this clip was OVA protein so that you can see the result of our targeting antigen. The ultimate goal of McHug platform is to integrate several protein databases and provide the users with easy-understanding illustrations. <br>
+
<br>
So far, we are able to show you protein 3D structure on the top of the interface. You can easily zoom in and zoom out to peek every part of your protein. And even select a partial peptide sequence. The peptide sequence in the protein will light up and reveal its position in the 3D structure. Moreover, MHC binding affinity and protein annotations are shown below. Amino acid positions are arranged correspondingly so that you can check all the information side by side. McHug 2016 also features the visualized interface which can transform loads of numerical data into legible charts and all basic protein information are integrated into a canvas penal at the buttom of the page.
+
<div style="color:black;text-decoration:none;font-size:18px;margin-left:70px;">
 +
The biobrick parts, including 5’HYG, 3’UTR, HA and OVA, were synthesized directly by IDT. After receiving the synthesized parts, we used EcoRI and PstI to digest the parts and pSB1C3 backbone, then ligated and transformed the DNA samples into DH5a competent cells. According to the digestion and colony PCR results of the colony, all the parts were inserted into the pSB1C3 vector with the right length of DNA sequences, 5’HYG is 1446 bp, HA is 1700 bp, OVA is 2098 bp and 3’UTR is 774 bp.<br><br>
 +
<img src="https://static.igem.org/mediawiki/2016/e/e9/CGU_Taiwan--bio5.jpg" width=760px height=270px style="padding:6px;border:2px black solid;border-radius:8px;"></img><br><br>
 +
(Fig. 1) pSB1C3-3’UTR, pSB1C3-5’HYG, pSB1C3-OVA checked by colony PCR and enzyme digestion
 +
<br><br>
 +
(A),(C) The pSB1C3-3’UTR and pSB1C3-OVA were transformed and the colonies were picked to perform colony PCR. The forward primer sequence was 5’- GAATTCGCGGCCGCTTCTAGAG-3’, which was in the prefix site. And the reverse primer sequence was 5’-CTGCAGCGGCCGCTACTAGTA-3’, which was in the suffix site. The PCR reaction was performed with Taq polymerase, and screened in 0.8% agarose gel by electrophoresis. As the results, a 700~800 bp sequence was proliferated in pSB1C3-3’UTR, and a 2000~2500 bp sequence was proliferated from pSB1C3-OVA. (B) The pSB1C3-5’HYG was transformed and the colonies were picked and amplified in LB broth. pSB1C3-5’HYG plasmid was purified by miniprep, and digested with EcoRI and PstI for 4 hrs, then screened in 0.8% agarose gel by electrophoresis. The results showed a 2000 bp band of pSB1C3 and the 1500 bp 5’HYG.<br><br>
 +
<img src="https://static.igem.org/mediawiki/2016/2/2d/CGU_Taiwan--bio6.jpg" width=350px height=200px style="padding:6px;border:2px black solid;border-radius:8px;"></img><br><br>
 +
(Fig. 2) The basic part checked by PCR
 +
<br><br>
 +
We used pSB1C3-5’HYG, pSB1C3-3’UTR, pSB1C3-HA, pSB1C3-OVA as template, to check the length of the inserts. The PCR reaction was performed with Taq polymerase, and screened in 0.8% agarose gel by electrophoresis.  
 
</div>
 
</div>
 +
<br><br>
  
 +
<b style="font-size:20px;">(2) The construction of pSB1C3-HA-3’UTR and pSB1C3-OVA-3’UTR (<a href="http://parts.igem.org/Part:BBa_K1955006">BBa_K1955006</a>):</b>
 +
<br>
 +
<div style="color:black;text-decoration:none;font-size:18px;margin-left:70px;">
 +
The pSB1C3-3’UTR was digested with EcoRI and XbaI, then the pSB1C3-HA and pSB1C3-OVA were digested with EcoRI and SpeI. After the purifying step, the pSB1C3-3’UTR was ligated with HA and OVA, then transformed after 16℃ overnight. The colony were checked with colony PCR, as the results, the HA-3’UTR would be about 2.6 kb (1774 bp +774 bp), and the OVA-3’UTR would be about 2.9 kb (2098 bp +774 bp).<br><br>
 +
<img src="https://static.igem.org/mediawiki/2016/8/89/CGU_Taiwan--bio15.jpg" width=670px height=250px style="padding:6px;border:2px black solid;border-radius:8px;"></img>
 +
<br><br>
 +
pSB1C3-HA-3’UTR and pSB1C3-OVA-3’UTR checked by colony PCR
 +
<br><br>
 +
The pSB1C3-HA-3’UTR and pSB1C3-OVA-3’UTR were transformed and the colonies were picked to perform colony PCR. The PCR reaction was performed with Taq polymerase, and screened in 0.8% agarose gel by electrophoresis. The 2600 bp HA-3’ UTR and 2900 bp OVA-3’UTR were proliferated from pSB1C3-HA-3’UTR and pSB1C3-OVA-3’UTR.
 +
</div>
 +
<br><br>
  
 +
<b style="font-size:20px;">(3) The construction of pSB1C3-5’HYG-HA-3’UTR (<a href="http://parts.igem.org/Part:BBa_K1955005">BBa_K1955005</a>) and pSB1C3-5’HYG-OVA-3’UTR (<a href="http://parts.igem.org/Part:BBa_K1955006">BBa_K1955006</a>) : </b>
 +
<br>
 +
<div style="color:black;text-decoration:none;font-size:18px;margin-left:70px;">
 +
The pSB1C3-HA-3’UTR and pSB1C3-OVA-3’UTR were digested with EcoRI and XbaI, while the pSB1C3-5’UTR was digested with EcoRI and SpeI. The pSB1C3-HA-3’UTR, pSB1C3-OVA-3’UTR and 5’UTR were purified by gel extraction, and ligated together. After the transformation step, we used colony PCR to check the correctness of the plasmid. The results showed that the approximately 4100 bp long 5’HYG-HA-3’UTR (1446 bp +1700 bp + 774 bp) and 4500 bp 5’HYG-HA-3’UTR (1446 bp + 2098 bp+ 774 bp) could be amplified from the plasmid, meaning that the pSB1C3-HA-3’UTR, pSB1C3-OVA-3’UTR were finished in the step. In order to transfect the plasmid into leishmania by electroporation, we amplified the plasmid in 200 ml LB broth, and purified the DNA by midiprep.<br><br>
 +
<img src="https://static.igem.org/mediawiki/2016/1/1c/CGU_Taiwan--bio7.jpg" width=750px height=300px style="padding:6px;border:2px black solid;border-radius:8px;"></img>
 +
<br><br>
 +
pSB1C3-HA-3’UTR, pSB1C3-OVA-3’UTR checked by colony PCR
 +
<br><br>
 +
The pSB1C3-5’HYG-HA-3’UTR and pSB1C3-5’HYG-OVA-3’UTR were transformed and the colonies were picked to perform colony PCR. The PCR reaction was performed with Taq polymerase, and screened in 0.8% agarose gel by electrophoresis. The 4100 bp 5’HYG-HA-3’UTR and 4500 bp 5’HYG-OVA-3’UTR were amplified from pSB1C3-5’HYG-HA-3’UTR and pSB1C3-5’HYG-OVA-3’UTR.
 +
</div>
 +
<br><br>
 +
 +
<b style="font-size:20px;">(4) Construction of pSB1C3-2300 intron (<a href="http://parts.igem.org/Part:BBa_K1955001">BBa_K1955001</a>):</b>
 +
<br>
 +
<div style="color:black;text-decoration:none;font-size:18px;margin-left:70px;">
 +
Since the 2300 bp intrinsic sequence contained too many CG pairs, it couldn’t be synthesized. We used point mutation to change the nucleotide in the 2300 bp sequence, therefore, the sequence would be separated into 3 parts, the first and the second part were about 400~450 bp and the third part was approximately 1500 bp in length. Through the PCR, we could have these 3 parts amplified from p6.5 plasmid. We used the PCR-after-ligation strategy, ligating the first and second part together and performed PCR to amplify the sequence. Next, ligated the part 1 +part 2 sequence with part 3, and amplify the ligated parts with PCR again. The reason why we used the PCR-after-ligation strategy was because the ligation rate of the sequence was really low. However, although the parts of 2300 intron could be proliferated by PCR, we were unable to ligate the 3 parts together. The sequencing results of the 2300 intron always lost the second part, no matter what strategy we used in the construction. So, it turned out that we couldn’t put the 2300 intrinsic region into the final construction of our shuttle vector.
 +
<br><br>
 +
<img src="https://static.igem.org/mediawiki/2016/6/6f/CGU_Taiwan--bio16.jpg" width=550px height=350px style="border:2px black solid;border-radius:8px;"></img>
 +
<br><br>
 +
All the parts of 2300 intron checked by PCR
 +
<br><br>
 +
The PCR reaction was performed with Taq polymerase, and screened in 0.8% agarose gel by electrophoresis. Lane A to lane C were the three parts of 2300 intron, the first part was 400 bp, the second part was about 450 bp, and the third part was 1500 bp. Lane D was the ligation of part 1 + part 2, which would be approximately 800 bp. Lane E was the ligation of all three parts, which would be 2.3 kb in length. However, the second part would always be lost during the construction.
 +
</div>
 +
<br><br>
 +
 +
<b style="font-size:20px;">(5) Construction of pSB1C3-5’HYG-GFP-3’UTR (<a href="http://parts.igem.org/Part:BBa_K1955007">BBa_K1955007</a>)</b>
 +
<div style="color:black;text-decoration:none;font-size:18px;margin-left:70px;">
 +
Since we can’t detect the HA and OVA protein by western blotting after the pSB1C3-5’HYG-HA-3’UTR and pSB1C3-5’HYG-OVA-3’UTR plasmid were transfected into leishmania. We decided to construct pSB1C3-5’HYG-GFP-3’UTR in order to prove if our leishmania shuttle vector could express the second protein or not. The GFP sequence came from BBa_E0040 in the vector pSB1A2.
 +
<br><br>
 +
The pSB1C3-3’UTR was digested with EcoRI and XbaI, The pSB1A2-GFP and pSB1C3-5’HYG were digested with EcoRI and SpeI. After the purification, the pSB1C3-3’UTR was ligated with GFP and 5’HYG successively, then transformed into DH5a. The colonies were checked by colony PCR. The right length of GFP-3’UTR should be approximately 1.5 kb (720 bp +774 bp), while the 5’HYG-GFP-3’UTR should be about 3 kb (1446 bp +720 bp +774 bp). As the result, we knew that all the colonies contained the correct plasmid after the construction. The right colony of pSB1C3-5’HYG-GFP-3’UTR was picked and amplified in 200 ml LB broth, then the plasmid DNA was purified by midiprep.<br><br>
 +
<img src="https://static.igem.org/mediawiki/2016/b/bf/CGU_Taiwan--bio2.jpg" width=550px height=250px style="padding:6px;border:2px black solid;border-radius:8px;"></img>
 +
<br><br>
 +
pSB1C3-GFP-3’UTR and pSB1C3-5’HYG-GFP-3’UTR check by colony PCR
 +
<br><br>
 +
The PCR was performed with Taq polymerase, and screened in 0.8% agarose gel by electrophoresis. The GFP-3’UTR was about 1.5 kb in length, and the 5’HYG-GFP-3’UTR was about 3 kb.
 +
</div>
 +
<br><br>
 +
 +
<b style="font-size:20px;">(6) Restriction enzyme cutting of pSB1C3-OVA/HA and pSB1A2-GFP:</b>
 +
<br>
 +
<div style="color:black;text-decoration:none;font-size:18px;margin-left:70px;">
 +
Used EcoRIHF and XbaI to cut pSB1C3-OVA/HA and pSB1A2-GFP. Due to the short gap between EX restriction cutting site, it is hard to observe double band in the double enzyme digestion.<br><br>
 +
The whole length of pSB1C3-OVA/HA is approximately 4200bp/3800bp, and pSB1A2-GFP is 3000bp. By double enzyme digestion, all plasmids can be digested into one band (linear form) on the DNA gel.
 +
<br><br>
 +
<img src="https://static.igem.org/mediawiki/2016/d/d7/CGU_Taiwan--Results-1.png" width=550px height=350px style="border:2px black solid;border-radius:8px;"></img>
 +
<br><br>
 +
Fig. 1. Restriction enzyme cutting of pSB1C3-HA and pSB1A2-GFP.
 +
<br>
 +
Using EcoRIHF and XbaI with cutsmart enzyme buffer reaction for 3hr. Run a TAE gel for 45 min.
 +
<br><br>
 +
</div>
 +
 +
<b style="font-size:20px;">(7) Restriction enzyme cutting of pSB1C3-J04500:</b>
 +
<br>
 +
<div style="color:black;text-decoration:none;font-size:18px;margin-left:70px;">
 +
Utilized EcoRIHF and SpeI to digest pSB1C3-J04500, and served as the insert of ligation. J04500 is a 220bp DNA sequence, therefore a 2100bp (pSB1C3) and 220bp band(J04500) can be observed.<br><br>
 +
<img src="https://static.igem.org/mediawiki/2016/1/10/CGU_Taiwan--Results-2.png" width=550px height=400px style="border:2px black solid;border-radius:8px;"></img><br><br>
 +
Fig. 2. Restriction enzyme cutting of pSB1C3-J04500. Using EcoRIHF and SpeI with cutsmart enzyme buffer reaction for 3hr. Run a TAE gel for 45 min.
 +
<br><br>
 +
</div>
 +
 +
<b style="font-size:20px;">(8) Ligation and transformation of pSB1C3-J04500-HA and pSB1A2-J04500-GFP:</b>
 +
<br>
 +
<div style="color:black;text-decoration:none;font-size:18px;margin-left:70px;">
 +
According to the calculation of the ligation protocol, we can ligate pSB1C3-HA and pSB1A2-GFP with J04500. After ligation, transform 5μl sample into DH5α competent cell.<br><br>
 +
<img src="https://static.igem.org/mediawiki/2016/f/f7/CGU_Taiwan--Results-3.png" width=550px height=250px style="border:2px black solid;border-radius:8px;"></img><br><br>
 +
Fig. 3. Transformation of the ligation samples. After ligation overnight, transform 5 μl samples into DH5α competent cell following the transformation protocol. Pictures show the colonies of pSB1C3-J04500-HA and pSB1A2-J04500-GFP onto LB plate.
 +
<br><br>
 +
</div>
 +
 +
<b style="font-size:20px;">(9) Colony PCR check of pSB1C3-J04500-HA and pSB1A2-J04500-GFP colonies:</b>
 +
<br>
 +
<div style="color:black;text-decoration:none;font-size:18px;margin-left:70px;">
 +
With the primer for prefix and suffix, we easily picked up colonies and conducted colony PCR to check the transformation result. The colonies that had successfully insert J04500 into pSB1C3-HA, showed the band size of 220+1700bp (Fig. 4A). As for the negative control, we used pSB1C3-HA(1700 bp). The successful transformed pSB1A2-GFP inserted with J04500 showed the band size of 220+720 bp(Fig. 4B.) and used pSB1A2-GFP as our negative control.<br><br>
 +
<img src="https://static.igem.org/mediawiki/2016/6/62/CGU_Taiwan--Results-4.png" width=550px height=400px style="border:2px black solid;border-radius:8px;"></img><br><br>
 +
Fig. 4. Colony PCR check of the insertion of J04500 in pSB1C3-HA and pSB1A2-GFP with Taq DNA polymerase and primer for prefix and suffix. (A) Check the insertion of J04500 into pSB1C3- HA, pSB1C3- HA were as the negative control. (B) Check the insertion of J04500 into pSB1A2-GFP, pSB1A2-GFP was as the negative control.
 +
<br><br>
 +
</div>
 +
 +
<b style="font-size:20px;">(10) Transform pSB1C3-J04500-HA into BL21 to express desired gene and validate the normal function of J04500 by GFP:</b>
 +
<br>
 +
<div style="color:black;text-decoration:none;font-size:18px;margin-left:70px;">
 +
J04500 is a LacI inducible promoter, so it can be induced by IPTG to activate the promoter for transcription. We picked two colonies of pSB1C3-J04500-HA and pSB1A2-J04500-GFP and incubated in 4ml LB broth containing antibiotics at 37℃, 250rpm for overnight. Inoculate 4ml fresh LB supplemented with antibiotics with 20μl of overnight cultures. Shake cultures at 37℃, 250rpm for 3hr. Split cultures into two (2ml each) and add 2μl 1M IPTG to one of the tube to reach 1mM IPTG for induction. The other tube will be the uninduced control. Shake both tubes for another 3hrs at 37℃, 250rpm.
 +
<br><br>
 +
For the pSB1C3-J04500-HA, their induction can be checked by Coomassie blue or Western blot analysis. Transfer cultures from both tubes to two Eppendorf tubes and centrifuge bacteria at max speed for 3min. Discard the supernatant, and resuspend each pellet in 100μl 1x SDS sample buffer by pipetting. Fit cap-guards onto Eppendorf tubes and boil the samples at 100℃ for 10min. Run SDS-PAGE to check the expression of desired protein.
 +
<br><br>
 +
Conduct the Western blot analysis, we successfully recognize the HA protein (approximately 62.3kd) in our two colonies (JH1 and JH2) when induced by IPTG (Fig. 5A).
 +
<br><br>
 +
To check the feasibility of J04500, we also built up a construct containing J04500 and GFP. After induction of 3hrs, the induced bacteria turn fluorescent green. In contrast, the uninduced bacteria did not appear to have any color change. (Fig. 5B)
 +
<br><br>
 +
<img src="https://static.igem.org/mediawiki/2016/0/0d/CGU_Taiwan--Parts%26Results-5.png" width=500px height=550px style="padding:6px;border:2px black solid;border-radius:8px;"></img><br><br>
 +
Fig. 5. Protein expression of pSB1C3-HA and pSB1A2-GFP. The day before induction, two different colonies were picked up from each construct into 4ml LB broth at 37℃, 250rpm for overnight. Inoculated 4ml fresh LB broth with 20μl of overnight cultured at 37℃, 250rpm for 3hrs. Splited into two tubes(each 2ml), and added 2μl 1M IPTG to one tube as the induced group, the other tube without IPTG was the uninduced group. IPTG induction for 3~4hrs. (A) After IPTG induction, centrifuged bacteria at max speed. Discarded the supernatant, lysed the cell with 100μl 1x SDS sample buffer. Western blotting to check the desired gene expression. In fig. 5A, His-tag HA serves as positive control to validate that the antibody can work normally. We also transform pUC-19 into BL21 and follow the induction protocol as the negative control. (B) IPTG induction of pSB1A2-J04500-GFP to verify the LacI inducible promoter. The GFP fluorescence can be observed easily by bare eye.
 +
<br><br>
 +
</div>
 +
</div>
 +
 +
<div class="end2" style="margin-top:645%;">
 +
<br>
 +
<ul class="list3" class="margin-left:1%;margin-top:2%;">
 +
<li><a href="#anchor0"><b style="color:white;font-size:28px;margin-left:7%;">TOP</a></li>
 +
</ul>
 +
<br>
 +
<div class="sitemap" style="margin-left:5%;">
 +
<br>
 +
<b style="color:white;font-size:28px;margin-top:5%;margin-left:4%;text-decoration:none;">SITE MAP</b><br>
 +
<br><br>
 +
<img style="background-color:#0D014D;margin-left:20%;border-radius:50%;border:6px solid white;padding:5px;width:40%;height:70%;position:absolute;margin-left:2%;" src="https://static.igem.org/mediawiki/2016/0/03/CGU_Taiwan--leishmania3.jpg">
 +
</div>
 +
<br>
 +
 +
<div class="sitemap" style="margin-left:22%;margin-top:-1%;">
 +
<ul class="list1" class="margin-left:5%;">
 +
<li><a href="https://2016.igem.org/Team:CGU_Taiwan"><b style="color:white;font-size:18px;margin-left:20%;">HOME</li></a>
 +
<li><a href="https://2016.igem.org/Team:CGU_Taiwan/Achievements"><b style="color:white;font-size:18px;margin-left:20%;">ACHIEVEMENTS</li></a>
 +
<li><a href="https://2016.igem.org/Team:CGU_Taiwan/Interlab"><b style="color:white;font-size:18px;margin-left:20%;">INTERLAB</li></a>
 +
<li><a href="https://2016.igem.org/Team:CGU_Taiwan/Safety"><b style="color:white;font-size:18px;margin-left:20%;">SAFETY</li></a>
 +
<li><a href="https://2016.igem.org/Team:CGU_Taiwan/Parts"><b style="color:white;font-size:18px;margin-left:20%;">PARTS</li></a>
 +
</ul>
 +
</div>
 +
 +
<div class="sitemap" style="margin-left:40%;margin-top:-2%;">
 +
<ul class="list1" class="margin-left:5%;">
 +
<li><a href="https://2016.igem.org/Team:CGU_Taiwan/Description"><b style="color:white;font-size:18px;margin-left:20%;">PROJECT</li></a>
 +
<br><br>
 +
<ul class="list2" class="margin-left:6%;margin-top:50%;">
 +
<li><a href="https://2016.igem.org/Team:CGU_Taiwan/Design"><b style="color:white;font-size:17px;margin-left:10%;">Design</li></a>
 +
<li><a href="https://2016.igem.org/Team:CGU_Taiwan/Background"><b style="color:white;font-size:17px;margin-left:10%;">Background</li></a>
 +
<li><a href="https://2016.igem.org/Team:CGU_Taiwan/Results"><b style="color:white;font-size:17px;margin-left:10%;">Results</li></a>
 +
<li><a href="https://2016.igem.org/Team:CGU_Taiwan/Proof"><b style="color:white;font-size:17px;margin-left:10%;">Proof</li></a>
 +
<li><a href="https://2016.igem.org/Team:CGU_Taiwan/Notebook"><b style="color:white;font-size:17px;margin-left:10%;">Notebook</li></a>
 +
<br><br>
 +
</ul>
 +
</ul>
 +
</div>
 +
 +
<div class="sitemap" style="margin-left:55%;margin-top:-3.5%;">
 +
<ul class="list1" class="margin-left:5%;">
 +
<li><a href="https://2016.igem.org/Team:CGU_Taiwan/Human_Practices"><b style="color:white;font-size:18px;margin-left:20%;">HUMAN PRACTICES</li></a>
 +
<br><br>
 +
<ul class="list2" class="margin-left:6%;margin-top:50%;">
 +
<li><a href="https://2016.igem.org/Team:CGU_Taiwan/Human_Practices_Survey"><b style="color:white;font-size:17px;margin-left:10%;">Survey</li></a>
 +
<li><a href="https://2016.igem.org/Team:CGU_Taiwan/Human_Practices_Education"><b style="color:white;font-size:17px;margin-left:10%;">Education</li></a>
 +
<li><a href="https://2016.igem.org/Team:CGU_Taiwan/Human_Practices_Communication"><b style="color:white;font-size:17px;margin-left:10%;">Communication</li></a>
 +
<li><a href="https://2016.igem.org/Team:CGU_Taiwan/Entrepreneurship"><b style="color:white;font-size:17px;margin-left:10%;">Entrepreneurship</li></a>
 +
</ul>
 +
</ul>
 +
</div>
 +
 +
<div class="sitemap" style="margin-left:75%;margin-top:-3.5%;">
 +
<ul class="list1" class="margin-left:5%;">
 +
<li><a href="https://2016.igem.org/Team:CGU_Taiwan/Software"><b style="color:white;font-size:18px;margin-left:20%;">MODELING</li></a>
 +
<br><br>
 +
<ul class="list2" class="margin-left:6%;">
 +
<li><a href="http://163.25.92.36/igemcgu/igemwebhome.htm"><b style="color:white;font-size:17px;margin-left:10%;">McHug</li></a>
 +
</ul>
 +
</ul>
 +
<ul class="list1" class="margin-left:1%;margin-top:-10%;">
 +
<li><a href="https://2016.igem.org/Team:CGU_Taiwan/Team"><b style="color:white;font-size:18px;margin-left:20%;">OUR TEAM</li></a>
 +
<br><br>
 +
<ul class="list2" class="margin-left:6%;margin-top:-5%;">
 +
<li><a href="https://2016.igem.org/Team:CGU_Taiwan/Collaborations"><b style="color:white;font-size:17px;margin-left:10%;">Collaborations</li></a>
 +
<li><a href="https://2016.igem.org/Team:CGU_Taiwan/Attributions"><b style="color:white;font-size:17px;margin-left:10%;">Attributions</li></a>
 +
<li><a href="https://2016.igem.org/Team:CGU_Taiwan/Team#anchor2"><b style="color:white;font-size:17px;margin-left:10%;">Sponsors</li></a>
 +
</ul>
 +
</ul>
 +
</div>
 +
</div>
  
  

Latest revision as of 08:37, 2 December 2016


Biobricks


1. Basic part:
BBa_K1955000 : pSB1C3-Hemagglutinin
BBa_K1955001: pSB1C3-2.3intron
BBa_K1955002: pSB1C3-3'UTR
BBa_K1955003: pSB1C3-5'HYG
BBa_K1955004: pSB1C3-Ova

2. Composite parts:
BBa_K1955005 : pSB1C3-5'HYG-HA-3'UTR
BBa_K1955006 : pSB1C3-5'HYG-OVA-3'UTR
BBa_K1955007 : pSB1C3-5'HYG-GFP-3'UTR
BBa_K1955008 : pSB1C3-lacI inducible Hemagglutinin
BBa_K1955010 : pSB1A2-lacI inducible GFP



(1) Insert 5’HYG (BBa_K1955003), 3’UTR (BBa_K1955002), HA (BBa_K1955000) and OVA (BBa_K1955004) gBlocks into pSB1C3 vector:
The biobrick parts, including 5’HYG, 3’UTR, HA and OVA, were synthesized directly by IDT. After receiving the synthesized parts, we used EcoRI and PstI to digest the parts and pSB1C3 backbone, then ligated and transformed the DNA samples into DH5a competent cells. According to the digestion and colony PCR results of the colony, all the parts were inserted into the pSB1C3 vector with the right length of DNA sequences, 5’HYG is 1446 bp, HA is 1700 bp, OVA is 2098 bp and 3’UTR is 774 bp.



(Fig. 1) pSB1C3-3’UTR, pSB1C3-5’HYG, pSB1C3-OVA checked by colony PCR and enzyme digestion

(A),(C) The pSB1C3-3’UTR and pSB1C3-OVA were transformed and the colonies were picked to perform colony PCR. The forward primer sequence was 5’- GAATTCGCGGCCGCTTCTAGAG-3’, which was in the prefix site. And the reverse primer sequence was 5’-CTGCAGCGGCCGCTACTAGTA-3’, which was in the suffix site. The PCR reaction was performed with Taq polymerase, and screened in 0.8% agarose gel by electrophoresis. As the results, a 700~800 bp sequence was proliferated in pSB1C3-3’UTR, and a 2000~2500 bp sequence was proliferated from pSB1C3-OVA. (B) The pSB1C3-5’HYG was transformed and the colonies were picked and amplified in LB broth. pSB1C3-5’HYG plasmid was purified by miniprep, and digested with EcoRI and PstI for 4 hrs, then screened in 0.8% agarose gel by electrophoresis. The results showed a 2000 bp band of pSB1C3 and the 1500 bp 5’HYG.



(Fig. 2) The basic part checked by PCR

We used pSB1C3-5’HYG, pSB1C3-3’UTR, pSB1C3-HA, pSB1C3-OVA as template, to check the length of the inserts. The PCR reaction was performed with Taq polymerase, and screened in 0.8% agarose gel by electrophoresis.


(2) The construction of pSB1C3-HA-3’UTR and pSB1C3-OVA-3’UTR (BBa_K1955006):
The pSB1C3-3’UTR was digested with EcoRI and XbaI, then the pSB1C3-HA and pSB1C3-OVA were digested with EcoRI and SpeI. After the purifying step, the pSB1C3-3’UTR was ligated with HA and OVA, then transformed after 16℃ overnight. The colony were checked with colony PCR, as the results, the HA-3’UTR would be about 2.6 kb (1774 bp +774 bp), and the OVA-3’UTR would be about 2.9 kb (2098 bp +774 bp).



pSB1C3-HA-3’UTR and pSB1C3-OVA-3’UTR checked by colony PCR

The pSB1C3-HA-3’UTR and pSB1C3-OVA-3’UTR were transformed and the colonies were picked to perform colony PCR. The PCR reaction was performed with Taq polymerase, and screened in 0.8% agarose gel by electrophoresis. The 2600 bp HA-3’ UTR and 2900 bp OVA-3’UTR were proliferated from pSB1C3-HA-3’UTR and pSB1C3-OVA-3’UTR.


(3) The construction of pSB1C3-5’HYG-HA-3’UTR (BBa_K1955005) and pSB1C3-5’HYG-OVA-3’UTR (BBa_K1955006) :
The pSB1C3-HA-3’UTR and pSB1C3-OVA-3’UTR were digested with EcoRI and XbaI, while the pSB1C3-5’UTR was digested with EcoRI and SpeI. The pSB1C3-HA-3’UTR, pSB1C3-OVA-3’UTR and 5’UTR were purified by gel extraction, and ligated together. After the transformation step, we used colony PCR to check the correctness of the plasmid. The results showed that the approximately 4100 bp long 5’HYG-HA-3’UTR (1446 bp +1700 bp + 774 bp) and 4500 bp 5’HYG-HA-3’UTR (1446 bp + 2098 bp+ 774 bp) could be amplified from the plasmid, meaning that the pSB1C3-HA-3’UTR, pSB1C3-OVA-3’UTR were finished in the step. In order to transfect the plasmid into leishmania by electroporation, we amplified the plasmid in 200 ml LB broth, and purified the DNA by midiprep.



pSB1C3-HA-3’UTR, pSB1C3-OVA-3’UTR checked by colony PCR

The pSB1C3-5’HYG-HA-3’UTR and pSB1C3-5’HYG-OVA-3’UTR were transformed and the colonies were picked to perform colony PCR. The PCR reaction was performed with Taq polymerase, and screened in 0.8% agarose gel by electrophoresis. The 4100 bp 5’HYG-HA-3’UTR and 4500 bp 5’HYG-OVA-3’UTR were amplified from pSB1C3-5’HYG-HA-3’UTR and pSB1C3-5’HYG-OVA-3’UTR.


(4) Construction of pSB1C3-2300 intron (BBa_K1955001):
Since the 2300 bp intrinsic sequence contained too many CG pairs, it couldn’t be synthesized. We used point mutation to change the nucleotide in the 2300 bp sequence, therefore, the sequence would be separated into 3 parts, the first and the second part were about 400~450 bp and the third part was approximately 1500 bp in length. Through the PCR, we could have these 3 parts amplified from p6.5 plasmid. We used the PCR-after-ligation strategy, ligating the first and second part together and performed PCR to amplify the sequence. Next, ligated the part 1 +part 2 sequence with part 3, and amplify the ligated parts with PCR again. The reason why we used the PCR-after-ligation strategy was because the ligation rate of the sequence was really low. However, although the parts of 2300 intron could be proliferated by PCR, we were unable to ligate the 3 parts together. The sequencing results of the 2300 intron always lost the second part, no matter what strategy we used in the construction. So, it turned out that we couldn’t put the 2300 intrinsic region into the final construction of our shuttle vector.



All the parts of 2300 intron checked by PCR

The PCR reaction was performed with Taq polymerase, and screened in 0.8% agarose gel by electrophoresis. Lane A to lane C were the three parts of 2300 intron, the first part was 400 bp, the second part was about 450 bp, and the third part was 1500 bp. Lane D was the ligation of part 1 + part 2, which would be approximately 800 bp. Lane E was the ligation of all three parts, which would be 2.3 kb in length. However, the second part would always be lost during the construction.


(5) Construction of pSB1C3-5’HYG-GFP-3’UTR (BBa_K1955007)
Since we can’t detect the HA and OVA protein by western blotting after the pSB1C3-5’HYG-HA-3’UTR and pSB1C3-5’HYG-OVA-3’UTR plasmid were transfected into leishmania. We decided to construct pSB1C3-5’HYG-GFP-3’UTR in order to prove if our leishmania shuttle vector could express the second protein or not. The GFP sequence came from BBa_E0040 in the vector pSB1A2.

The pSB1C3-3’UTR was digested with EcoRI and XbaI, The pSB1A2-GFP and pSB1C3-5’HYG were digested with EcoRI and SpeI. After the purification, the pSB1C3-3’UTR was ligated with GFP and 5’HYG successively, then transformed into DH5a. The colonies were checked by colony PCR. The right length of GFP-3’UTR should be approximately 1.5 kb (720 bp +774 bp), while the 5’HYG-GFP-3’UTR should be about 3 kb (1446 bp +720 bp +774 bp). As the result, we knew that all the colonies contained the correct plasmid after the construction. The right colony of pSB1C3-5’HYG-GFP-3’UTR was picked and amplified in 200 ml LB broth, then the plasmid DNA was purified by midiprep.



pSB1C3-GFP-3’UTR and pSB1C3-5’HYG-GFP-3’UTR check by colony PCR

The PCR was performed with Taq polymerase, and screened in 0.8% agarose gel by electrophoresis. The GFP-3’UTR was about 1.5 kb in length, and the 5’HYG-GFP-3’UTR was about 3 kb.


(6) Restriction enzyme cutting of pSB1C3-OVA/HA and pSB1A2-GFP:
Used EcoRIHF and XbaI to cut pSB1C3-OVA/HA and pSB1A2-GFP. Due to the short gap between EX restriction cutting site, it is hard to observe double band in the double enzyme digestion.

The whole length of pSB1C3-OVA/HA is approximately 4200bp/3800bp, and pSB1A2-GFP is 3000bp. By double enzyme digestion, all plasmids can be digested into one band (linear form) on the DNA gel.



Fig. 1. Restriction enzyme cutting of pSB1C3-HA and pSB1A2-GFP.
Using EcoRIHF and XbaI with cutsmart enzyme buffer reaction for 3hr. Run a TAE gel for 45 min.

(7) Restriction enzyme cutting of pSB1C3-J04500:
Utilized EcoRIHF and SpeI to digest pSB1C3-J04500, and served as the insert of ligation. J04500 is a 220bp DNA sequence, therefore a 2100bp (pSB1C3) and 220bp band(J04500) can be observed.



Fig. 2. Restriction enzyme cutting of pSB1C3-J04500. Using EcoRIHF and SpeI with cutsmart enzyme buffer reaction for 3hr. Run a TAE gel for 45 min.

(8) Ligation and transformation of pSB1C3-J04500-HA and pSB1A2-J04500-GFP:
According to the calculation of the ligation protocol, we can ligate pSB1C3-HA and pSB1A2-GFP with J04500. After ligation, transform 5μl sample into DH5α competent cell.



Fig. 3. Transformation of the ligation samples. After ligation overnight, transform 5 μl samples into DH5α competent cell following the transformation protocol. Pictures show the colonies of pSB1C3-J04500-HA and pSB1A2-J04500-GFP onto LB plate.

(9) Colony PCR check of pSB1C3-J04500-HA and pSB1A2-J04500-GFP colonies:
With the primer for prefix and suffix, we easily picked up colonies and conducted colony PCR to check the transformation result. The colonies that had successfully insert J04500 into pSB1C3-HA, showed the band size of 220+1700bp (Fig. 4A). As for the negative control, we used pSB1C3-HA(1700 bp). The successful transformed pSB1A2-GFP inserted with J04500 showed the band size of 220+720 bp(Fig. 4B.) and used pSB1A2-GFP as our negative control.



Fig. 4. Colony PCR check of the insertion of J04500 in pSB1C3-HA and pSB1A2-GFP with Taq DNA polymerase and primer for prefix and suffix. (A) Check the insertion of J04500 into pSB1C3- HA, pSB1C3- HA were as the negative control. (B) Check the insertion of J04500 into pSB1A2-GFP, pSB1A2-GFP was as the negative control.

(10) Transform pSB1C3-J04500-HA into BL21 to express desired gene and validate the normal function of J04500 by GFP:
J04500 is a LacI inducible promoter, so it can be induced by IPTG to activate the promoter for transcription. We picked two colonies of pSB1C3-J04500-HA and pSB1A2-J04500-GFP and incubated in 4ml LB broth containing antibiotics at 37℃, 250rpm for overnight. Inoculate 4ml fresh LB supplemented with antibiotics with 20μl of overnight cultures. Shake cultures at 37℃, 250rpm for 3hr. Split cultures into two (2ml each) and add 2μl 1M IPTG to one of the tube to reach 1mM IPTG for induction. The other tube will be the uninduced control. Shake both tubes for another 3hrs at 37℃, 250rpm.

For the pSB1C3-J04500-HA, their induction can be checked by Coomassie blue or Western blot analysis. Transfer cultures from both tubes to two Eppendorf tubes and centrifuge bacteria at max speed for 3min. Discard the supernatant, and resuspend each pellet in 100μl 1x SDS sample buffer by pipetting. Fit cap-guards onto Eppendorf tubes and boil the samples at 100℃ for 10min. Run SDS-PAGE to check the expression of desired protein.

Conduct the Western blot analysis, we successfully recognize the HA protein (approximately 62.3kd) in our two colonies (JH1 and JH2) when induced by IPTG (Fig. 5A).

To check the feasibility of J04500, we also built up a construct containing J04500 and GFP. After induction of 3hrs, the induced bacteria turn fluorescent green. In contrast, the uninduced bacteria did not appear to have any color change. (Fig. 5B)



Fig. 5. Protein expression of pSB1C3-HA and pSB1A2-GFP. The day before induction, two different colonies were picked up from each construct into 4ml LB broth at 37℃, 250rpm for overnight. Inoculated 4ml fresh LB broth with 20μl of overnight cultured at 37℃, 250rpm for 3hrs. Splited into two tubes(each 2ml), and added 2μl 1M IPTG to one tube as the induced group, the other tube without IPTG was the uninduced group. IPTG induction for 3~4hrs. (A) After IPTG induction, centrifuged bacteria at max speed. Discarded the supernatant, lysed the cell with 100μl 1x SDS sample buffer. Western blotting to check the desired gene expression. In fig. 5A, His-tag HA serves as positive control to validate that the antibody can work normally. We also transform pUC-19 into BL21 and follow the induction protocol as the negative control. (B) IPTG induction of pSB1A2-J04500-GFP to verify the LacI inducible promoter. The GFP fluorescence can be observed easily by bare eye.